Literature DB >> 3160601

Motor nerve conduction velocity and nerve polyols in mice with short-term genetic or streptozotocin-induced diabetes.

S J Whiteley, D R Tomlinson.   

Abstract

This study examined the relation between sciatic motor nerve conduction velocity and sciatic nerve contents of sorbitol, fructose, and myo-inositol in diabetic mice. Two groups of spontaneously diabetic animals (age 12 to 14 weeks and age 20 weeks) were compared with age-matched controls. In another experiment 17-week-old nondiabetic mice (of the same strain) were administered streptozotocin to induce diabetes and were subject to similar measurements 3 weeks later; age-matched controls were studied concomitantly. The diabetic mice in all groups were hyperglycemic with elevated nerve glucose. Those made diabetic with streptozotocin also showed a weight loss during the 3 weeks of diabetes. However, none of the diabetic groups showed significant deficits of motor nerve conduction velocity or nerve myo-inositol content. No accumulations of sorbitol or fructose were found in the sciatic nerves of the mice with diabetes of either origin. The study concluded that these animals do not have sciatic nerve aldose reductase activity and are not subject to myo-inositol depletion or to motor nerve conduction velocity deficits in short-term diabetes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3160601     DOI: 10.1016/0014-4886(85)90092-5

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

1.  The effects of sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat.

Authors:  N E Cameron; M B Leonard; I S Ross; P H Whiting
Journal:  Diabetologia       Date:  1986-03       Impact factor: 10.122

2.  Diabetic neuropathy in db/db mice develops independently of changes in ATPase and aldose reductase. A biochemical and immunohistochemical study.

Authors:  R Bianchi; C Marelli; P Marini; M Fabris; C Triban; M G Fiori
Journal:  Diabetologia       Date:  1990-03       Impact factor: 10.122

3.  SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy.

Authors:  Andrea M Vincent; James W Russell; Kelli A Sullivan; Carey Backus; John M Hayes; Lisa L McLean; Eva L Feldman
Journal:  Exp Neurol       Date:  2007-08-03       Impact factor: 5.330

4.  Tangzhining exhibits a protective effect against cognitive dysfunction in diabetic rats.

Authors:  Xiaomei Song; Wei Wang; Yaguo Kang; Xin Zhang; Yi Jiang; Zhenggang Yue; Zhishu Tang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 5.  Criteria for creating and assessing mouse models of diabetic neuropathy.

Authors:  Kelli A Sullivan; Stephen I Lentz; John L Roberts; Eva L Feldman
Journal:  Curr Drug Targets       Date:  2008-01       Impact factor: 3.465

6.  Phenotypic changes in diabetic neuropathy induced by a high-fat diet in diabetic C57BL/6 mice.

Authors:  B L Guilford; J M Ryals; D E Wright
Journal:  Exp Diabetes Res       Date:  2011-11-14

Review 7.  Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes.

Authors:  Bingxuan Wang; P Charukeshi Chandrasekera; John J Pippin
Journal:  Curr Diabetes Rev       Date:  2014-03

8.  Characterization of diabetic neuropathy progression in a mouse model of type 2 diabetes mellitus.

Authors:  Cristian De Gregorio; David Contador; Mario Campero; Marcelo Ezquer; Fernando Ezquer
Journal:  Biol Open       Date:  2018-09-05       Impact factor: 2.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.